Affordable Access

Antiviral treatment of Argentine hemorrhagic fever.

Authors
  • Enria, D A
  • Maiztegui, J I
Type
Published Article
Journal
Antiviral Research
Publisher
Elsevier
Publication Date
Jan 01, 1994
Volume
23
Issue
1
Pages
23–31
Identifiers
PMID: 8141590
Source
Medline
License
Unknown

Abstract

Argentine hemorrhagic fever is a systemic viral disease caused by Junin virus, with a mortality of 15-30% in untreated individuals. Current specific therapy is highly effective in reducing mortality, and consists of the early administration of immune plasma in defined doses of specific neutralizing antibodies per kg of body weight. However, several reasons suggest the need to investigate alternative therapies. Ribavirin, a broad spectrum antiviral agent, is effective in the treatment of other viral hemorrhagic fevers, and the studies done with Junin virus infections to date indicate that this drug may also have a beneficial effect in Argentine hemorrhagic fever.

Report this publication

Statistics

Seen <100 times